SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-002223
Filing Date
2019-02-12
Accepted
2019-02-12 15:41:56
Documents
1
Group Members
ANDREW MARTINKEVIN RUSSELL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sc13g1218a2ubsoconn_protalix.htm SC 13G/A 76633
  Complete submission text file 0001213900-19-002223.txt   78408
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 19590513
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

IRS No.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A